as 10-28-2025 9:33am EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Upcoming Earnings Alert:
Get ready for potential market movements as Bruker Corporation BRKR prepares to release earnings report on 03 Nov 2025.
| Founded: | 1960 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 5.3B | IPO Year: | 2000 |
| Target Price: | $49.67 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.52 | EPS Growth: | -78.23 |
| 52 Week Low/High: | $28.53 - $64.64 | Next Earning Date: | 11-03-2025 |
| Revenue: | $3,442,800,000 | Revenue Growth: | 10.36% |
| Revenue Growth (this year): | 4.3% | Revenue Growth (next year): | 1.51% |
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Friend Cynthia M | BRKR | Director | Sep 12 '25 | Sell | $32.25 | 3,535 | $113,989.96 | 18,016 |
BRKR Breaking Stock News: Dive into BRKR Ticker-Specific Updates for Smart Investing
Insider Monkey
8 days ago
Simply Wall St.
22 days ago
Zacks
22 days ago
StockStory
25 days ago
MT Newswires
25 days ago
Business Wire
25 days ago
StockStory
a month ago
StockStory
2 months ago
The information presented on this page, "BRKR Bruker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.